eli lilly tirzepatide shortage launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can FDA makes end of Zepbound,

Studies show Ozempic does not result in lasting damage to the eyes

"Unfamiliarity with withdrawing medication from a vial into a syringe and coupled with confusion between different units of measurement (e.g., milliliters, milligrams and "units") may have contributed to dosing errors." The agency said patients should consult with a medical professional on how to measure and administer the correct dose, and that health care providers should "provide patients with the appropriate syringe size for the intended dose and counsel patients on how to measure the intended dose using the syringe." Semaglutide is the active ingredient in three FDA-approved medications, Wegovy, Ozempic and Rybelsus

Neuroendocrinology (2021) 111(7):66077

Viking plans to start Phase 3 trials of the oral tablet formulation of VK2735 in the fourth quarter

It changes how your brain responds to food cues

Your Initial Consultation How much is Zepbound